CCEL
Price:
$6.075
Market Cap:
$49.10M
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company marke...[Read more]
Industry
Medical - Care Facilities
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
CCEL
According to Cryo-Cell International, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 61.47M. This represents a change of -11.74% compared to the average of 69.65M of the last 4 quarters.
The mean historical Enterprise Value of Cryo-Cell International, Inc. over the last ten years is 58.33M. The current 61.47M Enterprise Value has changed 10.44% with respect to the historical average. Over the past ten years (40 quarters), CCEL's Enterprise Value was at its highest in in the November 2021 quarter at 99.20M. The Enterprise Value was at its lowest in in the May 2015 quarter at 21.54M.
Average
58.33M
Median
57.44M
Minimum
28.50M
Maximum
95.30M
Discovering the peaks and valleys of Cryo-Cell International, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.39%
Maximum Annual Enterprise Value = 95.30M
Minimum Annual Increase = -50.78%
Minimum Annual Enterprise Value = 28.50M
Year | Enterprise Value | Change |
---|---|---|
2024 | 74.39M | 34.97% |
2023 | 55.11M | 17.50% |
2022 | 46.90M | -50.78% |
2021 | 95.30M | 67.39% |
2020 | 56.93M | -13.65% |
2019 | 65.93M | 7.14% |
2018 | 61.53M | 6.20% |
2017 | 57.94M | 42.02% |
2016 | 40.80M | 43.16% |
2015 | 28.50M | 3.58% |
The current Enterprise Value of Cryo-Cell International, Inc. (CCEL) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
58.80M
5-year avg
65.73M
10-year avg
58.33M
Cryo-Cell International, Inc.’s Enterprise Value is less than National HealthCare Corporation (1.56B), less than InnovAge Holding Corp. (465.78M), less than The Pennant Group, Inc. (1.08B), less than Encompass Health Corporation (10.10B), less than Aesthetic Medical International Holdings Group Limited (213.99M), less than AirSculpt Technologies, Inc. (238.03M), less than Aveanna Healthcare Holdings Inc. (2.33B), less than The Oncology Institute, Inc. (129.95M), less than Brookdale Senior Living Inc. (2.35B), less than Surgery Partners, Inc. (6.53B), less than Select Medical Holdings Corporation (3.12B), less than The Ensign Group, Inc. (8.96B), less than Pediatrix Medical Group, Inc. (1.63B), less than P3 Health Partners Inc. (140.23M), less than Sonida Senior Living, Inc. (1.09B), less than Acadia Healthcare Company, Inc. (4.73B), greater than DocGo Inc. (-32054438898025.00), less than Concord Medical Services Holdings Limited (3.45B),
Company | Enterprise Value | Market cap |
---|---|---|
1.56B | $1.42B | |
465.78M | $465.24M | |
1.08B | $833.21M | |
10.10B | $9.83B | |
213.99M | $15.93M | |
238.03M | $141.81M | |
2.33B | $1.08B | |
129.95M | $54.40M | |
2.35B | $1.22B | |
6.53B | $3.10B | |
3.12B | $2.19B | |
8.96B | $7.45B | |
1.63B | $1.20B | |
140.23M | $58.60M | |
1.09B | $455.01M | |
4.73B | $2.72B | |
-32054438898025.00 | $288.10M | |
3.45B | $687.43K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cryo-Cell International, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cryo-Cell International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cryo-Cell International, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cryo-Cell International, Inc. (CCEL)?
What is the 3-year average Enterprise Value for Cryo-Cell International, Inc. (CCEL)?
What is the 5-year average Enterprise Value for Cryo-Cell International, Inc. (CCEL)?
How does the current Enterprise Value for Cryo-Cell International, Inc. (CCEL) compare to its historical average?